{"id":"W2075096471","doi":"10.1007/s00280-011-1657-1","title":"A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202","year":2011,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Capecitabine; Gemcitabine; Medicine; Internal medicine; Gallbladder cancer; Gallbladder; Gastroenterology; Regimen; Cancer; Oncology; Biliary tract cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002902586,0.002330988,0.003529501,0.000698265,0.0006756378,0.001359903,0.00125692,0.00183791,0.00641241],"category_scores_gemma":[0.002104566,0.001074006,0.003018991,0.0009418587,0.001484245,0.001427688,0.000659208,0.004248297,0.001092755],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001357733,"about_ca_system_score_gemma":0.002573329,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003177215,"about_ca_topic_score_gemma":0.008760241,"domain_scores_codex":[0.9987447,0.0008511686,0.00005298448,0.0001455474,0.00004985674,0.0001556203],"domain_scores_gemma":[0.9981644,0.0003685567,0.0002949685,0.000180354,0.00008782479,0.0009039976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9468976,0.02097524,0.004179334,0.0003955235,0.00181254,0.0001219924,0.0001750666,0.001006101,0.005288774,0.0001422523,0.002186241,0.01681944],"study_design_scores_gemma":[0.8318219,0.1605909,0.005171483,0.00001777069,0.0005187725,0.00007144253,0.00006456154,0.0002802547,0.0003923352,0.00007666843,0.0009771725,0.00001670519],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924028,0.001953236,0.0002686308,0.0007464996,0.0002156452,0.001415515,0.001235821,0.00006045972,0.00170128],"genre_scores_gemma":[0.9841698,0.00263015,0.001336759,0.001556926,0.000346776,0.002327746,0.003508325,0.00004111497,0.004082306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00641241,"threshold_uncertainty_score":0.02145165,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05717419124661998,"score_gpt":0.355581271116952,"score_spread":0.298407079870332,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}